Informations générales (source: ClinicalTrials.gov)
Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization
Observational
University Hospital, Tours (Voir sur ClinicalTrials)
juillet 2006
juin 2009
29 juin 2024
Contrast-enhanced ultrasound is supposed to improve the detection of myomas as well as
improve the follow-up after specific treatments like embolization. It will also help the
investigators better understand the mechanism of success or failure for embolization and
could reduce the amount of particles injected by determining the endpoint of the
procedure in order to treat the myomas while preserving the myometrium.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre d'Innovation Technologique-Ultrasons - 37344 - Tours - France | Henri MARRET, Pr | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- Uterine myomas with solid tissue (greater diameter lower than 15 cm)
- The embolization is planified during the 15 days after the contrast ultrasonography
- Written informed consent is signed
- Uterine myomas with solid tissue (greater diameter lower than 15 cm)
- The embolization is planified during the 15 days after the contrast ultrasonography
- Written informed consent is signed
- Intracavitary uterine mass possibly due to a polyp or endometrial cancer
- Necessity of using the endovaginal way of ultrasonography because of the myoma's
size and accessibility
- Menopause
- Pregnancy and breastfeeding
- Recent cardiac affection
- History of acute cardiac disease